These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3737478)

  • 1. Morphometry of breast cancer. I. Comparison of the primary tumours and the axillary lymph node metastases.
    Van der Linden HC; Baak JP; Smeulders AW; Lindeman J; Meyer CJ
    Pathol Res Pract; 1986 May; 181(2):236-42. PubMed ID: 3737478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
    Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
    van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
    J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
    Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
    Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
    Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
    Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
    Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
    Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour.
    Colpaert C; Vermeulen P; Jeuris W; van Beest P; Goovaerts G; Weyler J; Van Dam P; Dirix L; Van Marck E
    J Pathol; 2001 Apr; 193(4):442-9. PubMed ID: 11276002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometrical assessment of mean nuclear area in breast cancer in comparison with that of lymph node metastases.
    Tosi P; Luzi P; Sforza V; Spina D; Miracco C; Santopietro R
    Pathol Res Pract; 1985 Nov; 180(5):498-501. PubMed ID: 4080632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear profiles of cancer cells reveal the metastatic potential of gastric cancer.
    Ikeguchi M; Cai J; Oka S; Gomyou Y; Tsujitani S; Maeta M; Kaibara N
    J Pathol; 2000 Sep; 192(1):19-25. PubMed ID: 10951395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometry of isolated tumor cells in breast cancer sentinel lymph nodes: metastases or displacement?
    van Deurzen CH; Bult P; de Boer M; Koelemij R; van Hillegersberg R; Tjan-Heijnen VC; Hobbelink MG; de Bruin PC; van Diest PJ
    Am J Surg Pathol; 2009 Jan; 33(1):106-10. PubMed ID: 18852675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer.
    Sakakibara M; Fujimori T; Miyoshi T; Nagashima T; Fujimoto H; Suzuki HT; Ohki Y; Fushimi K; Yokomizo J; Nakatani Y; Miyazaki M
    Cancer; 2012 Aug; 118(16):3899-910. PubMed ID: 22180194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of nucleolar organizer regions for the lymph node spread and prognosis of invasive ductal mammary carcinoma.
    Bockmühl U; Theissig F; Dimmer V; Kunze KD
    Pathol Res Pract; 1991 May; 187(4):437-43. PubMed ID: 1652128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary tumour characteristics and axillary lymph node status in breast cancer.
    Yiangou C; Shousha S; Sinnett HD
    Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.